Tianjin, People’s Republic of China, 27 June 2016 – Quid, headquartered in San Francisco, was today awarded as one of the World Economic Forum’s Technology Pioneers, a selection of the world’s most innovative companies. Quid is software that searches, analyzes and visualizes the world’s collective intelligence to help answer [...]
Endeavour Medtech Growth (EMG) Fund final close at EUR 250m (USD 275m) EMG is the largest fund in Europe dedicated to medtech Fund oversubscribed – significantly exceeds EUR 150m target Fund to allocate between EUR 10m and EUR 20m per investment St Peter Port, Guernsey – 22 March 2016 [...]
Lausanne/Ecublens, Switzerland, September 1, 2015 – Symetis SA, a leading Swiss medical technology company, focused on transcatheter aortic valve implantation (TAVI), announced today its intention to float its shares and list on SIX Swiss Exchange in 2015. Proceeds from the initial public offering (IPO) will enable the company to [...]
Redwood City, CA – July 22, 2015 – Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has raised $43 million in an equity financing. The equity financing was co-led by new investor Endeavour Vision, a technology [...]
Zurich‐Schlieren, July 07, 2015. Molecular Partners AG (ticker: MOLN) today announced that its partner Allergan has initiated phase III clinical trials with abicipar pegol (abicipar) for the treatment of wet age‐related macular degeneration (wet AMD). The event triggered a clinical milestone payment to Molecular Partners of USD 15 million. [...]
Acquisition Supports Strategy to Expand into Higher Value Storage Platforms and Systems IRVINE and MILPITAS, Calif., March 3, 2015 /PRNewswire/ — Western Digital® Corporation (NASDAQ: WDC) announced today that HGST has entered into a definitive agreement to acquire Amplidata, a privately-held developer of object storage software for public and [...]
Acquisition Expands Merck’s Oncology Portfolio with Novel Oral BET Inhibitor, OTX015 KENILWORTH, N.J., Dec. 18, 2014 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has acquired, through a subsidiary, OncoEthix, a Swiss-based privately held biotechnology company specializing in oncology drug [...]
Zurich-Schlieren, December 5, 2014. Molecular Partners AG announces that the total offer size of the initial public offering (“IPO”) amounts to CHF 106.2 million, of which gross proceeds from the primary shares issued are CHF 104.1 million. The Joint Bookrunners of Molecular Partners’ IPO have partially exercised the over-allotment [...]
MOUNTAIN VIEW, Calif., Dec. 4, 2014 /PRNewswire/ — PneumRx, Inc. www.pneumrx.com, a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be acquired by BTG Plc (LSE:BTG) in a deal worth up to $475 million, based on an initial consideration of $230 [...]
Zurich-Schlieren, November 4, 2014. Molecular Partners AG has successfully re-launched its Initial Public Offering (IPO). Due to strong interest and demand from both international and Swiss institutional and private investors, Molecular Partners accelerated the timetable and closed the bookbuilding process yesterday, Monday, 5pm CET. Molecular Partners AG has successfully [...]